Donor selection for adoptive cell therapy with CD45RA− memory T cells for COVID-19 patients, and dexamethasone and interleukin-15 effect on the phenotype, proliferation and interferon gamma release
We have previously demonstrated the safety and feasibility of adoptive cell therapy with CD45RA − memory T cells containing SARS-CoV-2-specific T cells for COVID-19 patients from an unvaccinated donor who was chosen based on human leukocyte antigen compatibility and cellular response. In this study,...
Gespeichert in:
Veröffentlicht in: | Cytotherapy (Oxford, England) England), 2022-12 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!